Keyword: Novartis

News

Novartis to Shutter a Sandoz US Plant

09.09.2022 -

In advance of the planned spinoff of generics subsidiary Sandoz into a standalone generics producer, Novartis has announced it is closing one of the subsidiary’s US...

News

Novartis Sued over its own Drug

06.09.2022 -

Swiss drugmaker Novartis, already embroiled in a number of lawsuits against generics producers seeking to create copies of its blockbuster cardiac insufficiency treatment...

News

Novartis Definitely Plans to Spin off Sandoz

29.08.2022 -

Novartis has finally confirmed definite plans to spin off its generic drugs arm Sandoz.

News

Novartis Confirms 8,000 Global Jobs Will be Axed

29.06.2022 -

Novartis has confirmed reports by Swiss daily newspaper Tages-Anzeiger that it plans to slash 8,000 jobs worldwide.

News

Novartis Pledges to Fight Tropical Diseases and Malaria

28.06.2022 -

Swiss drugmaker Novartis has made a five-year financial commitment of $250 million to fight neglected tropical diseases (NTDs) and malaria.

News

Samsung Biologics in $81 Million Deal with Novartis

13.06.2022 -

In the their first-ever collaboration, South Korea’s Samsung Biologics and Switzerland’s Novartis have inked an initial $81 million contract manufacturing and development...

News

Sandoz Launches Generic Combigan Drops

19.04.2022 -

Novartis subsidiary Sandoz has launched a generic version of Combigan, the ocular hypertensiondrug made by AbbVie’s Allergan arm. The copy of the off-patent eye drops...

News

Novartis Creates new Innovative Medicines Unit

05.04.2022 -

Swiss pharma powerhouse Novartis is merging its pharmaceuticals and oncology businesses into a new unit called Innovative Medicines (IM). The restructuring that will...